|
?:authorAffiliation
|
-
[\'Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.\', \'Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.\', \'Department of Hematology, Mayo Clinic, Rochester, MN, USA.\', \'Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\', \'Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.\', \'Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.\', \'Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.\', \'Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.\', \'Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.\', \'Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA.\', \'Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Hematology, IRCCS Ca\' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.\', \'Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.\', \'MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK.\', \'Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.\', \'Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.\', \'Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.\', \'Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.\', \'Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.\', \'Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA.\', \'Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.\', \'Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA.\', \'Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.\', \'Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA.\', \'Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.\', \'Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.\', \'Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.\', \'Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA.\', \'Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France.\', \'Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany.\', \'Department of Medicine, University of Florence Medical School, Florence, Italy.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}